Grace Therapeutics, Inc. Other Accrued Liabilities, Current
Grace Therapeutics, Inc. (GRCE) had Other Accrued Liabilities, Current of $176.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Accounts Payable and Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Other Accrued Liabilities, Current $176.00K.
- 2026-03-31: Other Accrued Liabilities, Current $719.00K; Other Accrued Liabilities, Current as first filed $527.00K.
- 2025-12-31: Other Accrued Liabilities, Current $195.00K.
- 2025-09-30: Other Accrued Liabilities, Current $35.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $176.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $719.00K 10-Q · filed 2026-08-13 | $527.00K 10-K · filed 2026-06-18 |
| 2025-12-31 | $195.00K 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $35.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $36.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $103.00K 10-K · filed 2026-06-18 | |
| 2024-12-31 | $814.00K 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $626.00K 10-Q · filed 2024-11-13 | |
| 2024-03-31 | $43.00K 10-K · filed 2025-06-23 | $176.00K 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |